Zhang S - Search Results

1

Design, synthesis, and biological evaluation of chalcone oxime derivatives as potential immunosuppressive agents.

Luo Y, Song R, Li Y, Zhang S, Liu ZJ, Fu J, Zhu HL. Luo Y, et al. Among authors: zhang s. Bioorg Med Chem Lett. 2012 May 1;22(9):3039-43. doi: 10.1016/j.bmcl.2012.03.080. Epub 2012 Mar 28. Bioorg Med Chem Lett. 2012. PMID: 22494616

2

Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.

Li Y, Luo Y, Hu Y, Zhu DD, Zhang S, Liu ZJ, Gong HB, Zhu HL. Li Y, et al. Among authors: zhang s. Bioorg Med Chem. 2012 Jul 15;20(14):4316-22. doi: 10.1016/j.bmc.2012.05.050. Epub 2012 May 30. Bioorg Med Chem. 2012. PMID: 22710102

3

Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors.

Luo Y, Zhang LR, Hu Y, Zhang S, Fu J, Wang XM, Zhu HL. Luo Y, et al. Among authors: zhang lr, zhang s. ChemMedChem. 2012 Sep;7(9):1587-93. doi: 10.1002/cmdc.201200225. Epub 2012 Jul 18. ChemMedChem. 2012. PMID: 22811397

4

Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.

Luo Y, Zhang S, Qiu KM, Liu ZJ, Yang YS, Fu J, Zhong WQ, Zhu HL. Luo Y, et al. Among authors: zhang s. Bioorg Med Chem Lett. 2013 Feb 15;23(4):1091-5. doi: 10.1016/j.bmcl.2012.12.010. Epub 2012 Dec 20. Bioorg Med Chem Lett. 2013. PMID: 23312949

5

Synthesis and antimicrobical evaluation of a novel class of 1,3,4-thiadiazole: derivatives bearing 1,2,4-triazolo[1,5-a]pyrimidine moiety.

Luo Y, Zhang S, Liu ZJ, Chen W, Fu J, Zeng QF, Zhu HL. Luo Y, et al. Among authors: zhang s. Eur J Med Chem. 2013 Jun;64:54-61. doi: 10.1016/j.ejmech.2013.04.014. Epub 2013 Apr 15. Eur J Med Chem. 2013. PMID: 23644188

6

Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.

Zhang S, Luo Y, He LQ, Liu ZJ, Jiang AQ, Yang YH, Zhu HL. Zhang S, et al. Bioorg Med Chem. 2013 Jul 1;21(13):3723-9. doi: 10.1016/j.bmc.2013.04.043. Epub 2013 Apr 23. Bioorg Med Chem. 2013. PMID: 23673215

7

Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors.

Wang Z, Liu R, Zhang X, Chang X, Gao M, Zhang S, Guan Q, Sun J, Zuo D, Zhang W. Wang Z, et al. Among authors: zhang s, zhang w, zhang x. Bioorg Med Chem. 2022 Mar 15;58:116671. doi: 10.1016/j.bmc.2022.116671. Epub 2022 Feb 17. Bioorg Med Chem. 2022. PMID: 35193066

8

Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors.

Liu R, Zhang S, Huang M, Guo Z, Li L, Li M, Wu L, Guan Q, Zhang W. Liu R, et al. Among authors: zhang s, zhang w. Bioorg Chem. 2021 Oct;115:105220. doi: 10.1016/j.bioorg.2021.105220. Epub 2021 Jul 29. Bioorg Chem. 2021. PMID: 34352709

9

Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.

Liu R, Huang M, Zhang S, Li L, Li M, Sun J, Wu L, Guan Q, Zhang W. Liu R, et al. Among authors: zhang s, zhang w. Eur J Med Chem. 2021 Dec 15;226:113826. doi: 10.1016/j.ejmech.2021.113826. Epub 2021 Sep 11. Eur J Med Chem. 2021. PMID: 34571171

10

The LGMN pseudogene promotes tumor progression by acting as a miR-495-3p sponge in glioblastoma.

Liao K, Qian Z, Zhang S, Chen B, Li Z, Huang R, Cheng L, Wang T, Yang R, Lan J, Lu X, Kong L, Song X, Qiu Y, Lin Y. Liao K, et al. Among authors: zhang s. Cancer Lett. 2020 Oct 10;490:111-123. doi: 10.1016/j.canlet.2020.07.012. Epub 2020 Jul 22. Cancer Lett. 2020. PMID: 32711096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84,946 results

Search Page

Filters